KemPharm, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €340.99M +17.2% €197.28M +26.5% 57.9% +0.042 pp €153.79M +17.4% 45.1% +0.00056 pp
    (estimated) €290.83M +34.1% €156.01M +47.8% 53.6% +0.050 pp €131.01M +56.7% 45.0% +0.065 pp
    (estimated) €216.87M +61.2% €105.52M +270.5% 48.7% +0.27 pp €83.63M +93.8% 38.6% +0.065 pp
    (estimated) €134.50M +54.3% €28.48M -53.0% 21.2% -0.48 pp €43.15M -410.6% 32.1% +0.48 pp
    (estimated) €87.19M +327.9% €60.62M -166.6% 69.5% +5.2 pp -€13.89M -76.9% -15.9% +2.8 pp
    €20.38M -14.0% -€91.06M +129.1% -446.9% -2.8 pp -€60.12M +109.6% -295.0% -1.7 pp
    €23.70M +170.3% -€39.74M +72.0% -167.7% +0.96 pp -€28.69M +78.5% -121.0% +0.62 pp
    €8.77M -64.5% -€23.11M +212.9% -263.5% -2.3 pp -€16.07M -276.7% -183.3% -2.2 pp
    €24.73M +115.6% -€7.38M -33.0% -29.9% +0.66 pp €9.10M -653.0% 36.8% +0.51 pp
    €11.47M +3.5% -€11.01M -48.0% -96.0% +0.95 pp -€1.64M -92.0% -14.3% +1.7 pp
    €11.08M +∞% -€21.16M -56.6% -191.0% -1.9 pp -€20.46M -56.2% -184.7% -1.8 pp
    €0.00 +NaN% -€48.73M +30.1% N/A -€46.76M +64.6% N/A
    €0.00 +NaN% -€37.44M +162.7% N/A -€28.41M +13.0% N/A
    €0.00 +NaN% -€14.25M -69.8% N/A -€25.14M +44.7% N/A
    €0.00 +NaN% -€47.18M +123.5% N/A -€17.38M +37.7% N/A
    €0.00 +NaN% -€21.11M +367.9% N/A -€12.62M +242.0% N/A
    €0.00 +NaN% -€4.51M +7,321.6% N/A -€3.69M -3.2% N/A
    €0.00 -€60.77K N/A -€3.81M N/A

    Notifications